Country: Australia
Bahasa: Inggeris
Sumber: APVMA (Australian Pesticides and Veterinary Medicines Authority)
PERGOLIDE MESYLATE
RANVET PTY. LIMITED
pergolide mesylate(1mg/5mL)
ORAL SOLUTION/SUSPENSION
PERGOLIDE MESYLATE AMINO Active 1.0 mg/5ml
200mL
VM - Veterinary Medicine
HORSE | PONY | COLT | DONKEY | ENDURANCE HORSE | FILLY | FOAL | GELDING | HIGH PERFORMANCE HORSES | HORSES AT STUD | MARE | PACE
ENDOCRINE SYSTEM
CUSHINGS DISEASE | HYPERADRENOCORTISISM | PITUITARY DEPENDENT HYPERDRENO
Poison schedule: 4; Withholding period: MEAT WHP (HORSES): NOT TO BE USED in h orse intended for human consumption.; Host/pest details: HORSE: [CUSHINGS DISEASE]; PONY: [CUSHINGS DISEASE]; Poison schedule: 4; Withholding period: ; Host/pest details: HORSE: [CUSHINGS DISEASE]; PONY: [CUSHINGS DISEASE]; Aids in the therapy of equine Cushing's syndrome.This product is contraindicated in horses hypersensitive to it or other ergot derivatives. Use with caution in pregnant or lactating mares as safe use in these groups has not been established.
Registered
2022-07-01
R T PT LTD ANVE ty Ranvet's Pergolide - Main Panel Date: September 13, 2010 Version: 3 Page 1 of 1 CIN : 000 Carton Label Anything above this line is not draft / text label. PRESCRIPTION ANIMAL REMEDY KEEP OUT OF REACH OF CHILDREN FOR ANIMAL TREATMENT ONLY RANVET'S PERGOLIDE Active Constituent: Pergalide mesylate 1mg/5mL Aids in the therapy of equine Cushing's syndrome 200 mL RLP APPROVED Info PEST Verified RANVET PTY LTD Ranvet's Pergolide - Ancillary Panels Date: September 13, 2010 Version: 3 Page 2 of 1 CIN : 000 Carton Label Anything above this line is not draft / text label. INDICATlONS Pergolide mesylate is a potent dopamine agonist for the control of clinical signs associated with equine Cushing's syndrome in horses and ponies. These signs may include lethargy ; long, poor-quality hair coat that fails to shed; weight loss; pot-bellied appearance ; dry scaly skin; skin infections; polyuria (increased frequency of urination) and polydipsia (increased drinking) ; chronic laminitis and colic . DIRECTIONS FOR USE Contraindications: This product is contraindicated in horses hypersensitive to it or other ergot derivatives. Precautions: Use with caution in pregnant or lactating mares as safe use in these groups has not been established. Dosage and administration: Administer orally over the tongue once daily. A syringe should be used for accurate dose measurement. An initial starting dose of 0.002mg/kg (1 mg/500kg bodyweight) daily is recommended. Each 5mLdose provides 1mg pergolide mesylate. The dose may be gradually increased if clinical improvement fails to occur after one to two months of therapy. Consult your veterinarian before altering the recommended dose. If the dose is to be increased it is recommended that 0.5mg increments be assessed before higher daily doses are employed. A favourable clinical response to therapy will be associated with improvement or normalisation of results in the dexamethasone suppression and plasma ACTH tests and an improvement in clinical signs . Treatment will be required for t Baca dokumen lengkap